Reliance Industries Ltd’s (RIL) consolidated Ebitda inched up just 0.7% year-on-year to ₹44,141 crore in the March quarter (Q4FY26). Ordinarily, that wouldn’t cheer investors—but given the impact of ...

Reliance Industries Ltd (RIL), the Mukesh Ambani-led oil-to-telecom conglomerate, will announce its Q4 results on Friday. The meeting of the Board of Directors of the company is scheduled to be held ...

Giant Eagle is a regional supermarket chain and retail pharmacy that operates more than 200 Giant Eagle and Market District retail locations throughout Ohio, Pennsylvania, West Virginia, Maryland and ...

April 27 (Reuters) - Meta Platforms (META.O), opens new tab has signed an agreement with Overview Energy to secure power from the startup's space-based solar energy infrastructure for the Facebook ...

India’s oil-to-chemicals to new energy conglomerate, Reliance Industries, posted a 12.5% YoY decline in profit in Q4FY26 as margins slipped. The company reported a consolidated net profit of Rs 16,971 ...

Brokerages expect Reliance Industries (RIL)’s earnings to grow on the back of growth in Jio and retail businesses, but they expect moderate growth in oil to chemicals (O2C)segment in the coming ...

Reliance Industries Q4 FY26 Earnings Preview: The conglomerate's revenue for the quarter is estimated at Rs 2.81 lakh crore. The O2C segment faces mixed impact from Middle East disruptions. On the ...

Reliance Industries is set to announce its Q4 FY26 results, with analysts predicting a largely flat performance due to a slump in the oil-to-chemicals (O2C) business and muted retail growth, despite ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

Trump says he doesn't know if he backs constitutional due process rights in new interview President Donald Trump is circumspect about his duties to uphold due process rights laid out in the ...

Process chemistry involves the development and optimization of production processes for chemical compounds, and the scaling up of laboratory reactions, particularly in the pharmaceutical sector. This ...